The mRNA expression of fibrosis markers, including MMP-1, -2, -3, and -9, α-smooth muscle actin, fibronectin, and connective tissue growth factor was significantly attenuated in keloid fibroblasts after rucaparib treatment (20 μM) (Fig. 4). The gene discussed is CCN2; the disease is keloid.